This capability supports a specific role of AD-MSCs in the therapeutic resolution of OA synovial inflammation, as well as providing evidence that IFNγ-activated M1-like macrophages represent a good cell model capable of testing AD-MSCs activity [30]. This evidence concerns the gene IFNG and Alzheimer disease.